Comparison of the Effects of Topical Levobunolol and Timolol Solution on the Human Ocular Surface

Cornea

Volumn 22, Issue 8, 2003, Pages 709-715

  Ishibashi, Takeshi ^a   Yokoi, Norihiko ^b   Kinoshita, Shigeru ^b  

^a KYOTO PREFECTURAL UNIVERSITY OF MEDICINE   (Japan)

^b NONE

Author keywords

Corneal epithelial barrier function; Levobunolol hydrochloride; Precorneal tear film stability; Radius of tear meniscus; Timolol maleate

Indexed keywords

LEVOBUNOLOL; MIROL; TIMOLOL; TIMOLOL MALEATE;

ADULT; ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; CORNEA; CORNEA EPITHELIUM; DRUG EFFECT; FEMALE; FLUOROPHOTOMETRY; HUMAN; HUMAN EXPERIMENT; LACRIMAL FLUID LEVEL; LACRIMATION; MALE; NORMAL HUMAN; PRIORITY JOURNAL;

ADRENERGIC BETA-ANTAGONISTS; ADULT; CONTRAST MEDIA; CORNEA; EPITHELIUM, CORNEAL; EYE; FEMALE; FLUORESCEIN; HUMANS; IRRITANTS; LEVOBUNOLOL; MALE; MIDDLE AGED; REFERENCE VALUES; SOLUTIONS; TEARS; TIMOLOL;

EID: 0242318358     PISSN: 02773740     EISSN: None     Source Type: Journal    
DOI: 10.1097/00003226-200311000-00001     Document Type: Article

References (31)

1. Yablonski ME, Zimmerman TJ, Waltman SR, et al. A fluorophotometric study of the effect of topical timolol on aqueous humor dynamics. Exp Eye Res. 1978;27:135-142.
2. Weissman SS, Asbell PA. Effects of topical timolol (0.5%) and betaxolol (0.5%) on corneal sensitivity. Br J Ophthalmol. 1990;74:409-412.
3. Niiya A, Yokoi N, Matsumoto Y, et al. Effect of beta-blocker eyedrops on corneal epithelial barrier function. Ophthalmologica. 2000;214:332-336.
4. De Jong C, Stolwijk T, Kuppens E, et al. Topical timolol with and without benzalkonium chloride: epithelial permeability and autofluorescence of the cornea in glaucoma. Graefes Arch Klin Exp Ophthalmol. 1994;232:221-224.
5. Bonomi L, Zavarise G, Noya E, et al. Effects of timolol on tear flow in human eyes. Graefes Arch Klin Exp Ophthalmol. 1980;213:19-22.
6. Kuppens EV, de Jong CA, Stolwijk TR, et al. Effect of timolol with and without preservative on the basal tear turnover in glaucoma. Br J Ophthalmol. 1995;79:339-342.
7. Shimazaki J, Hanada, Yagi Y, et al. Changes in ocular surface caused by antiglaucomatous eyedrops: prospective, randomized study for the comparison of 0.5% timolol vs. 0.12% unoprostone. Br J Ophthalmol. 2000;84:1250-1254.
8. Strempel I. The influence of topical β-blockers on the breakup time. Opbthalmologica. 1984;189:110-115.
9. Herreras JM, Pastor JC, Calonge M, et al. Ocular surface alteration after long-term treatment with anti-glaucomatous drug. Ophthalmology. 1992;99:1082-1088.
10. Sherwood MB, Grierson I, Millar L, et al. Long-term morphologic effects of anitiglaucoma drugs on the conjunctiva and Tenon's capsule in glaucomatous patients. Ophthalmology. 1989;96:327-335.
11. Mackie IA, Seal DV, Pescod JM. Beta-adrenergic receptor blocking drugs: tear lysozyme and immunological screening for adverse reaction. Br J Ophthalmol. 1977;61:354-359.
12. Cinotti A, Cinotti D, Grant W, et al. Levobunolol vs timolol for open-angle glaucoma and ocular hypertension. Am J Ophthalmol. 1985;99:11-17.
13. Berson FG, Cohen HB, Foerster RJ, et al. Levobunolol compared with timolol for the long-term control of elevated intraocular pressure. Arch Ophthalmol. 1985;103:379-382.
14. Rakofsky SI, Melamed S, Cohen JS, et al. A comparison of the ocular hypotensive efficacy of once-daily and twice-daily levobunolol treatment. Ophthalmology. 1989;96:8-11.
15. Derick RJ, Robin AL, Tielsch J, et al. Once-daily versus twice-daily levobunolol (0.5%) therapy. A cross-over study. Ophthalmology. 1992;99:424-429.
16. Schmetterer L, Strenn K, Findl O, et al. Effects of antiglaucoma drugs on ocular hemodynamics in healthy volunteers. Clin Pharmacol Ther. 1997;61:583-595.
17. Snibson GR, Greaves JL, Soper ND, et al. Ocular surface residence times of artificial tear solutions. Cornea. 1992;11:288-293.
18. Nelson JD, Farris RL. Sodium hyaluronate and polyvinyl alcohol artificial tear preparations. A comparison in patients with keratoconjunctivitis sicca. Arch Ophthalmol. 1988;106:484-487.
19. Yokoi N, Bron A, Tiffany J, et al. Reflective meniscometry: a non-invasive method to measure tear meniscus curvature. Br J Ophthalmol. 1999;83:92-97.
20. Oguz H, Yokoi N, Kinoshita S. The height and radius of the tear meniscus and methods for examining these parameters. Cornea. 2000;19:497-500.
21. Yokoi N, Takehisa Y, Kinoshita S. Correlation of tear lipid layer interference patterns with the diagnosis and severity of dry eye. Am J Ophthalmol. 1996;122:818-824.
22. Mengher LS, Bron AJ, Tonge SR, et al. A non-invasive instrument for clinical assessment of the pre-corneal tear film stability. Curr Eye Res. 1985;4:1-7.
23. Hirji N, Patel S, Callender M. Human tear film pre-rupture phase time (TP-RPT)-a non-invasive technique for evaluating the precorneal tear film using a novel keratometer mire. Ophthal Physiol Opt. 1989;9:139-142.
24. Yokoi N, Kinoshita S. Clinical evaluation of corneal epithelial barrier function with the slit-lamp fluorophotometer. Cornea. 1995;14:485-489.
25. Norn MS. Desiccation of the pre-corneal film: I Corneal wetting time. Acta Ophthalmol. 1969;47:856-880.
26. Lemp MA, Holly FJ. Recent advances in ocular surface chemistry. Am J Optom. 1970;47:669-672.
27. Mengher LS, Bron AJ, Tonge SR, et al. Effect of fluorescein instillation on the pre-corneal tear film stability. Curr Eye Res. 1985;4:9-12.
28. Strempel I. Effect of commercial beta blockers and their combination with artificial tears on the duration of tear film stability. Ophthalmologica. 1987;195:61-68.
29. Vareilles P, Schmitt C, Lotti VJ, et al. Experimental studies with timolol: a new ocular hypotensive agent. J Fr Ophthalmol. 1978;1:717-721.
30. Van Buskirk EM. Corneal anesthesia after timolol maleate therapy. Am J Ophthalmol. 1979;88:739-743.
31. Yokoi N, Sugita J, Komuro A, et al. Relation between tear volume and the radius of tear meniscus curvature. [ARVO Abstract] Invest Ophthalmol Vis Sci. 2000;41:S65.